rs4646

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000103.4(CYP19A1):​c.*161T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.701 in 752,108 control chromosomes in the GnomAD database, including 187,141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 37731 hom., cov: 32)
Exomes 𝑓: 0.70 ( 149410 hom. )

Consequence

CYP19A1
NM_000103.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.27

Publications

170 publications found
Variant links:
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
MIR4713HG (HGNC:53124): (MIR4713 host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 15-51210647-A-C is Benign according to our data. Variant chr15-51210647-A-C is described in ClinVar as Benign. ClinVar VariationId is 316467.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.733 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP19A1NM_000103.4 linkc.*161T>G 3_prime_UTR_variant Exon 10 of 10 ENST00000396402.6 NP_000094.2 P11511-1A0A024R5S8Q8IYG4Q8TCA4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP19A1ENST00000396402.6 linkc.*161T>G 3_prime_UTR_variant Exon 10 of 10 1 NM_000103.4 ENSP00000379683.1 P11511-1

Frequencies

GnomAD3 genomes
AF:
0.702
AC:
106604
AN:
151928
Hom.:
37705
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.693
Gnomad AMI
AF:
0.644
Gnomad AMR
AF:
0.571
Gnomad ASJ
AF:
0.769
Gnomad EAS
AF:
0.682
Gnomad SAS
AF:
0.623
Gnomad FIN
AF:
0.720
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.738
Gnomad OTH
AF:
0.681
GnomAD2 exomes
AF:
0.672
AC:
147573
AN:
219628
AF XY:
0.679
show subpopulations
Gnomad AFR exome
AF:
0.695
Gnomad AMR exome
AF:
0.485
Gnomad ASJ exome
AF:
0.749
Gnomad EAS exome
AF:
0.674
Gnomad FIN exome
AF:
0.716
Gnomad NFE exome
AF:
0.728
Gnomad OTH exome
AF:
0.701
GnomAD4 exome
AF:
0.701
AC:
420906
AN:
600062
Hom.:
149410
Cov.:
4
AF XY:
0.702
AC XY:
230169
AN XY:
327918
show subpopulations
African (AFR)
AF:
0.685
AC:
11795
AN:
17214
American (AMR)
AF:
0.496
AC:
20764
AN:
41872
Ashkenazi Jewish (ASJ)
AF:
0.754
AC:
15579
AN:
20656
East Asian (EAS)
AF:
0.707
AC:
24790
AN:
35052
South Asian (SAS)
AF:
0.627
AC:
42571
AN:
67900
European-Finnish (FIN)
AF:
0.720
AC:
28721
AN:
39914
Middle Eastern (MID)
AF:
0.726
AC:
2974
AN:
4094
European-Non Finnish (NFE)
AF:
0.735
AC:
250921
AN:
341184
Other (OTH)
AF:
0.708
AC:
22791
AN:
32176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
6761
13523
20284
27046
33807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1216
2432
3648
4864
6080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.702
AC:
106677
AN:
152046
Hom.:
37731
Cov.:
32
AF XY:
0.698
AC XY:
51840
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.693
AC:
28710
AN:
41452
American (AMR)
AF:
0.570
AC:
8700
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.769
AC:
2667
AN:
3468
East Asian (EAS)
AF:
0.682
AC:
3525
AN:
5168
South Asian (SAS)
AF:
0.625
AC:
3013
AN:
4820
European-Finnish (FIN)
AF:
0.720
AC:
7616
AN:
10580
Middle Eastern (MID)
AF:
0.759
AC:
223
AN:
294
European-Non Finnish (NFE)
AF:
0.738
AC:
50193
AN:
67970
Other (OTH)
AF:
0.682
AC:
1443
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1664
3329
4993
6658
8322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
826
1652
2478
3304
4130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.722
Hom.:
167351
Bravo
AF:
0.688
Asia WGS
AF:
0.639
AC:
2224
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Aromatase deficiency Benign:2
Dec 06, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.10
DANN
Benign
0.46
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4646; hg19: chr15-51502844; COSMIC: COSV53058004; COSMIC: COSV53058004; API